Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 2/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6707721 | 0.92 | PARP14 (0.41) | HDAC1POLBGSK3BALDH1A1GPR35 | |
| SCHEMBL6713469 | 0.92 | HDAC1 (0.37) | HDAC1HDAC3NPC1 | |
| SCHEMBL6713900 | 0.90 | GPR35 (0.44) | RAB9AHDAC1HDAC3POLBNPC1 | |
| SCHEMBL6710343 | 0.90 | RAB9A (0.42) | RAB9AHDAC1HDAC3POLBNPC1 | |
| SCHEMBL6710048 | 0.89 | HDAC3 (0.38) | HDAC1HDAC3 | |
| SCHEMBL6709957 | 0.88 | HDAC3 (0.41) | HDAC1HDAC3POLBGSK3BTP53 | |
| SCHEMBL6709996 | 0.88 | GSK3B (0.42) | HDAC1HDAC3POLBGSK3BALDH1A1 | |
| SCHEMBL6714403 | 0.87 | PARP14 (0.37) | HDAC1HDAC3POLBALDH1A1 | |
| SCHEMBL6708982 | 0.87 | GSK3B (0.40) | RAB9AHDAC1HDAC3POLBGSK3B | |
| SCHEMBL6707672 | 0.87 | RAB9A (0.40) | RAB9AHDAC1HDAC3POLBGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | RAB9A 3732/4885HDAC1 1910/4885HDAC3 2281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.